Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2006 3
2007 9
2008 5
2009 3
2010 8
2011 18
2012 13
2013 12
2014 12
2015 12
2016 8
2017 7
2018 6
2019 3
2020 5
2021 6
2022 10
2023 11
2024 6
2025 6
2026 10

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

157 results

Results by year

Filters applied: . Clear all
Page 1
Pharmacological and Nonpharmacological Treatments for Painful Diabetic Peripheral Neuropathy.
Jang HN, Oh TJ. Jang HN, et al. Diabetes Metab J. 2023 Nov;47(6):743-756. doi: 10.4093/dmj.2023.0018. Epub 2023 Sep 6. Diabetes Metab J. 2023. PMID: 37670573 Free PMC article. Review.
Diabetic peripheral neuropathy (DPN) is one of the most prevalent chronic complications of diabetes. ...Food and Drug Administration (FDA) has approved pregabalin, duloxetine, tapentadol, and the 8% capsaicin patch as drugs for the treatment of pain …
Diabetic peripheral neuropathy (DPN) is one of the most prevalent chronic complications of diabetes. ...Food and Drug Administ …
Comparison of amitriptyline supplemented with pregabalin, pregabalin supplemented with amitriptyline, and duloxetine supplemented with pregabalin for the treatment of diabetic peripheral neuropathic pain (OPTION-DM): a multicentre, double-blind, randomised crossover trial.
Tesfaye S, Sloan G, Petrie J, White D, Bradburn M, Julious S, Rajbhandari S, Sharma S, Rayman G, Gouni R, Alam U, Cooper C, Loban A, Sutherland K, Glover R, Waterhouse S, Turton E, Horspool M, Gandhi R, Maguire D, Jude EB, Ahmed SH, Vas P, Hariman C, McDougall C, Devers M, Tsatlidis V, Johnson M, Rice ASC, Bouhassira D, Bennett DL, Selvarajah D; OPTION-DM trial group. Tesfaye S, et al. Lancet. 2022 Aug 27;400(10353):680-690. doi: 10.1016/S0140-6736(22)01472-6. Epub 2022 Aug 22. Lancet. 2022. PMID: 36007534 Free PMC article. Clinical Trial.
BACKGROUND: Diabetic peripheral neuropathic pain (DPNP) is common and often distressing. Most guidelines recommend amitriptyline, duloxetine, pregabalin, or gabapentin as initial analgesic treatment for DPNP, but there is little comparative evidence on which …
BACKGROUND: Diabetic peripheral neuropathic pain (DPNP) is common and often distressing. Most guidelines recommend amitriptyline, …
Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia.
Lunn MP, Hughes RA, Wiffen PJ. Lunn MP, et al. Cochrane Database Syst Rev. 2014 Jan 3;2014(1):CD007115. doi: 10.1002/14651858.CD007115.pub3. Cochrane Database Syst Rev. 2014. PMID: 24385423 Free PMC article.
We also searched the reference lists of identified publications for trials of duloxetine for the treatment of painful peripheral neuropathy or chronic pain. SELECTION CRITERIA: We selected all randomised or quasi-randomised trials of any formulation of dul …
We also searched the reference lists of identified publications for trials of duloxetine for the treatment of painful peripher …
Evidence-Based Treatment of Painful Diabetic Neuropathy: a Systematic Review.
D'Souza RS, Barman R, Joseph A, Abd-Elsayed A. D'Souza RS, et al. Curr Pain Headache Rep. 2022 Aug;26(8):583-594. doi: 10.1007/s11916-022-01061-7. Epub 2022 Jun 18. Curr Pain Headache Rep. 2022. PMID: 35716275
PURPOSE OF REVIEW: Painful diabetic neuropathy (PDN) manifests with pain typically in the distal lower extremities and can be challenging to treat. ...First-line pharmacologic therapy for PDN includes gabapentinoids (pregabalin and gabapentin) and d …
PURPOSE OF REVIEW: Painful diabetic neuropathy (PDN) manifests with pain typically in the distal lower extremities and …
Diabetic peripheral neuropathy essentials: a narrative review.
Chang MC, Yang S. Chang MC, et al. Ann Palliat Med. 2023 Mar;12(2):390-398. doi: 10.21037/apm-22-693. Epub 2023 Feb 8. Ann Palliat Med. 2023. PMID: 36786097 Free article. Review.
BACKGROUND AND OBJECTIVE: Painful diabetic peripheral neuropathy (DPN) affects approximately 6-34% of all patients with diabetes. ...To identify potentially relevant articles, the following key search phrases were combined: 'diabetes mellitus', 'diabetes', ' …
BACKGROUND AND OBJECTIVE: Painful diabetic peripheral neuropathy (DPN) affects approximately 6-34% of all patients with …
Peripheral Neuropathy: A Review.
Mauermann ML, Staff NP. Mauermann ML, et al. JAMA. 2026 Jan 20;335(3):255-266. doi: 10.1001/jama.2025.19400. JAMA. 2026. PMID: 41247746 Review.
At least a 50% reduction in pain was observed in 38% of those with painful diabetic peripheral neuropathy receiving 1200 mg of gabapentin daily. Combination drug therapies for neuropathic pain may provide added benefit. ...Diabetes is the most common cause of …
At least a 50% reduction in pain was observed in 38% of those with painful diabetic peripheral neuropathy receiving 120 …
Management of diabetic neuropathy.
Cernea S, Raz I. Cernea S, et al. Metabolism. 2021 Oct;123:154867. doi: 10.1016/j.metabol.2021.154867. Epub 2021 Aug 17. Metabolism. 2021. PMID: 34411554 Review.
Diabetic neuropathy is a neurodegenerative disorder that may alter both the somatic and autonomic peripheral nervous systems in the context of diabetes mellitus (DM). ...Despite better understanding of the pathogenetic mechanisms of diabetic peripheral neu …
Diabetic neuropathy is a neurodegenerative disorder that may alter both the somatic and autonomic peripheral nervous systems i …
Painful diabetic neuropathy.
Peltier A, Goutman SA, Callaghan BC. Peltier A, et al. BMJ. 2014 May 6;348:g1799. doi: 10.1136/bmj.g1799. BMJ. 2014. PMID: 24803311 Review.
Diabetes is a worldwide epidemic, and associated neuropathy is its most costly and disabling complication. Given the rising prevalence of painful diabetic neuropathy, it is increasingly important that we understand the best ways to diagnose and treat t …
Diabetes is a worldwide epidemic, and associated neuropathy is its most costly and disabling complication. Given the rising prevalenc …
Diabetic Neuropathy: A Guide to Pain Management.
Zhang EX, Yazdi C, Islam RK, Anwar AI, Alvares-Amado A, Townsend H, Allen KE, Plakotaris E, Hirsch JD, Rieger RG, Allampalli V, Hasoon J, Islam KN, Shekoohi S, Kaye AD, Robinson CL. Zhang EX, et al. Curr Pain Headache Rep. 2024 Oct;28(10):1067-1072. doi: 10.1007/s11916-024-01293-9. Epub 2024 Jul 5. Curr Pain Headache Rep. 2024. PMID: 38967712 Review.
PURPOSE OF REVIEW: Diabetic neuropathy is a common complication of diabetes mellitus (DM) and can affect up to 50% of DM patients during their lifetime. ...The United States Food and Drug Administration (FDA) confirmed four drugs for painful diabetic …
PURPOSE OF REVIEW: Diabetic neuropathy is a common complication of diabetes mellitus (DM) and can affect up to 50% of DM patie …
Update on Treating Painful Diabetic Peripheral Neuropathy: A Review of Current US Guidelines with a Focus on the Most Recently Approved Management Options.
Mallick-Searle T, Adler JA. Mallick-Searle T, et al. J Pain Res. 2024 Mar 13;17:1005-1028. doi: 10.2147/JPR.S442595. eCollection 2024. J Pain Res. 2024. PMID: 38505500 Free PMC article. Review.
Painful diabetic peripheral neuropathy (DPN) is a highly prevalent and disabling complication of diabetes that is often misdiagnosed and undertreated. ...Four pharmacologic options are currently approved by the US Food and Drug Administration (FDA) to treat …
Painful diabetic peripheral neuropathy (DPN) is a highly prevalent and disabling complication of diabetes that is often …
157 results